Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Preferred Stock Liabilities (2018 - 2019)

Historic Preferred Stock Liabilities for Black Diamond Therapeutics (BDTX) over the last 2 years, with Q4 2019 value amounting to $200.6 million.

  • Black Diamond Therapeutics' Preferred Stock Liabilities rose 23005.27% to $200.6 million in Q4 2019 from the same period last year, while for Dec 2019 it was $200.6 million, marking a year-over-year increase of 23005.27%. This contributed to the annual value of $200.6 million for FY2019, which is 23005.27% up from last year.
  • According to the latest figures from Q4 2019, Black Diamond Therapeutics' Preferred Stock Liabilities is $200.6 million, which was up 23005.27% from $115.8 million recorded in Q3 2019.
  • In the past 5 years, Black Diamond Therapeutics' Preferred Stock Liabilities registered a high of $200.6 million during Q4 2019, and its lowest value of $60.8 million during Q4 2018.